Ballicules.com

Methyldopa

ALDOMET

Pronunciation: meth-il-DOE-pa

Methyldopa ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Methyldopa ballicule
Methyldopa ALDOMET mascot mnemonic cartoon
Visual mnemonic: Methyldopa mascot
“Metal dopa”

What it isCentral alpha-2 agonist through its active metabolite; hypertension, especially during pregnancy.

Why this oneIts exceptionally long pregnancy safety record keeps it useful despite poor tolerability outside pregnancy.

What limits itSedation is common; monitor for hepatitis and Coombs-positive hemolytic anemia.

Methyldopa molecular structure (skeletal formula)
Molecular structure: Methyldopa

FDA-approved for

Off-label

FDA label

FDA dosingPopulationStartTargetMax
HypertensionAdult250 mg BID–TID500 mg–2 g/day divided BID–QID3 g/day
HypertensionPediatric10 mg/kg/day divided BID–QID65 mg/kg or 3 g/day, whichever less

Titration Adjust at intervals of not less than 2 days

Renal Impaired renal function may respond to smaller doses

Hepatic Undefined

Instructions

Available strengths

Contraindications

Cautions

Adverse reactions

Pregnancy Use only if clearly needed; extensive human use suggests fetal harm remote

Lactation Undefined

Cost

Methyldopa (ALDOMET)
What pharmacies pay · NADAC 9/30/26
Strength#/mogeneric $/moCostPlus
250 mgtab60 BID$449.99not offered
500 mgtab60 BIDnot offered

NO BOXED WARNINGS

Principal riskCoombs-positive hemolytic anemia; sedation

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability1 / 4
Sedation liability1 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryB

Defining liabilitySedation, immune hemolytic anemia and hepatotoxicity

Active metabolites

Open Methyldopa in the interactive console ↗